Study for Adults with Compensated Liver Cirrhosis
Protocol: STUDY00008596
Full Title
A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efruxifermin in subjects with compensdated cirrhosis due to nonalcoholic steatohepatitis (NASH)/metabolic dysfunction-associated steatohepatitis (MASH)
Description
The University at Buffalo is recruiting adults living with compensated liver cirrhosis for a 5-year study. People with this diagnosis have scarring on their livers but their livers still function normally.

The study will include 3 months for screening, 5 years of study treatment, and a 30-day follow-up visit. This will involve up to 39 visits to the Study Doctor: every week for the first month, once a month for the following year and a half, and then every 3 months. Each study visit will take about 2 hours.

Participants will be randomly assigned (which happens by chance, like flipping a coin) to one of the following groups:
-Group 1: will receive a placebo (which looks like the study medicine but does not contain any active medication)
-Group 2: will receive 50mg of the study medicine

The placebo/study medicine will be injected by a needle into the soft tissue under the skin in the stomach or upper thigh once a week.

Participants may receive up to $1,650.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
-Adults 18 years or older
-Have been diagnosed with liver cirrhosis due to nonalcoholic steatohepatitis (NASH)/metabolic dysfunction-associated steatohepatitis (MASH)
-Not currently pregnant
Age Group: Adults
Principal Investigator: AJAY CHAUDHURI
ClinicalTrials.gov: Open Study
Contact(s)
RICHARD REJMAN
rmrejman@buffalo.edu
+1 716-878-3320

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions